Sittner & Nelson’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-20
Closed -$561 459
2023
Q3
$561 Hold
20
﹤0.01% 445
2023
Q2
$738 Sell
20
-11
-35% -$336 ﹤0.01% 458
2023
Q1
$928 Hold
31
﹤0.01% 466
2022
Q4
$949 Hold
31
﹤0.01% 437
2022
Q3
$1K Hold
31
﹤0.01% 431
2022
Q2
$1K Hold
31
﹤0.01% 456
2022
Q1
$1K Hold
31
﹤0.01% 426
2021
Q4
$1K Hold
31
﹤0.01% 418
2021
Q3
$1K Hold
31
﹤0.01% 393
2021
Q2
$1K Hold
31
﹤0.01% 372
2021
Q1
$1K Hold
31
﹤0.01% 381
2020
Q4
$1K Buy
+31
New +$738 ﹤0.01% 404

Other funds holding CC

Sittner & Nelson's CC Position: Q4 2023 in Review

Sittner & Nelson sold out of Chemours (CC) in Q4 2023, closing a stake of 20 shares — an estimated $561 sold.

Sittner & Nelson first reported a position in CC in Q4 2020 and held it in 12 quarters. The position peaked at $1K in Q3 2022. 469 funds tracked by Wall St. Rank hold CC as of Q4 2023.

  • Sittner & Nelson reported no remaining Chemours position as of Q4 2023 after selling out during the quarter.
  • Sittner & Nelson sold 20 Chemours shares in Q4 2023, an estimated $561.
  • Sittner & Nelson first reported a position in Chemours in Q4 2020 and held it in 12 quarters.
  • Sittner & Nelson's Chemours position peaked at $1K in Q3 2022.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q4 2023.

Based on Sittner & Nelson's 13F filing for Q4 2023, filed 13 Feb 2024.